Sutro Biopharma Inc (STRO) stock has gained 149.25% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives STRO stock a score of 70 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 81. STRO's rank also includes a fundamental score of 67. In addition to the average rating from Wall Street analysts, STRO stock has a mean target price of 30.833. This means analysts expect the stock to increase 43.34% over the next 12 months. The long-term technical score for STRO is 63.
What's Happening with STRO Stock Today
Sutro Biopharma Inc (STRO) stock is higher by 3.89% while the S&P 500 has gained 1.81% as of 11:36 AM on Tuesday, Mar 9. STRO has gained $0.80 from the previous closing price of $20.70 on volume of 177,475 shares. Over the past year the S&P 500 is higher by 41.66% while STRO has gained 149.25%. STRO lost -$0.09 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Sutro Biopharma Inc (STRO) Stock.
